Home/Companies/Alnylam Pharmaceuticals, Inc.
Company banner · Visible after claiming
Alnylam Pharmaceuticals, Inc. logo
Now Hiring

Alnylam Pharmaceuticals, Inc.

Life sciences job openings · Updated 2026-08-13

10+
Active openings
10+
US-based roles
0
Remote-friendly

Open Positions

10+ active openings
Senior Director, Quality Technology
Cambridge, MAPosted Jul 5
Scientist, Metabolomics
Cambridge, MAPosted Jul 21
Associate Director, Biostatistics
USPosted Jul 30
Director, Global Strategic Sourcing, Emerging Modalities & Quality
Cambridge, MAPosted Jul 24
Business Account Executive
USPosted Aug 13
Sign up free to see all 10+ openings

Top Hiring Locations

Cambridge, MA, US

Updates

2026 Alnylam 2030 strategy announced

May 13, 2026

2026 Alnylam 2030 strategy announced hmotawe Wed, 05/13/2026 - 16:15 2026 #fff Alnylam 2030 strategy announced 1 en https://investors.alnylam.com/press-release?id=29491 On

2026 Alnylam 2030 strategy announced

May 13, 2026

2026 Alnylam 2030 strategy announced hmotawe Wed, 05/13/2026 - 16:14 2026 #fff Alnylam 2030 strategy announced 1 en https://investors.alnylam.com/press-release?id=29491 Off

Silence Disease Ireland

Apr 20, 2026

Silence Disease Ireland maggi Mon, 04/20/2026 - 17:31 When RNAi silences the genes that cause disease, life can be amplified. Silence disease 1 Amplify life ® Slide Language Ir

FDA accepts Alnylam’s siRELIS TM enzymatic ligation manufacturing platform into its Emerging Technology Program, fast-tracking global regulatory engagement

Dec 17, 2025

FDA accepts Alnylam’s siRELIS TM enzymatic ligation manufacturing platform into its Emerging Technology Program, fast-tracking global regulatory engagement hmotawe Wed, 12/17/2025 - 20:35 2025 #fff FDA accepts Alnylam’s siRELIS TM enzymatic ligation manufacturing platform into its Emerging…

$250M expansion of Norton, MA (USA) manufacturing facility announced; expansion will add enzymatic ligation manufacturing capability to meet growing demand for RNAi therapeutics

Dec 17, 2025

$250M expansion of Norton, MA (USA) manufacturing facility announced; expansion will add enzymatic ligation manufacturing capability to meet growing demand for RNAi therapeutics hmotawe Wed, 12/17/2025 - 20:35 2025 #fff $250M expansion of Norton, MA (USA) manufacturing facility announced;…

$250M expansion of Norton, MA (USA) manufacturing facility announced; expansion will add enzymatic ligation manufacturing capability to meet growing demand for RNAi therapeutics

Dec 17, 2025

$250M expansion of Norton, MA (USA) manufacturing facility announced; expansion will add enzymatic ligation manufacturing capability to meet growing demand for RNAi therapeutics hmotawe Wed, 12/17/2025 - 20:30 2025 #fff $250M expansion of Norton, MA (USA) manufacturing facility announced;…

From official company newsrooms and press releases.

About Alnylam Pharmaceuticals, Inc.

Claim to unlock

Company description, mission, culture, and benefits — visible after this page is claimed and verified.

Find Your Role at Alnylam Pharmaceuticals, Inc.

Sign up free to search all 10+ openings with AI-powered matching.

Search Alnylam Pharmaceuticals, Inc. Jobs
← Browse all companies

Profile generated from publicly available hiring data.

·Are you Alnylam Pharmaceuticals, Inc.? Claim this page or contact us